Abstract
Managing risk of anaphylaxis in patients receiving allergen immunotherapy: Assessing benefit versus risk
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have